New perspectives on screening and early detection of endometrial cancer.
Laura CostasJon Frias-GomezMagdalena GuardiolaYolanda BenaventeMarta PinedaMiquel Á PavónJosé M MartínezMaite ClimentMarc BarahonaJúlia CanetSonia PaytubiMónica SalinasLuis PalomeroIlaria BianchiJaume ReventósGabriel CapellàMireia DiazAugust VidalJosep M PiulatsÁlvaro AytésJordi PonceJoan BrunetFrancesc X BoschXavier Matias-GuiuLaia AlemanySilvia de Sanjosénull nullPublished in: International journal of cancer (2019)
Due to the anatomical continuity of the uterine cavity with the cervix, genomic exploitation of material from routine Pap smears and other noninvasive sampling methods represent a unique opportunity to detect signs of disease using biological material shed from the upper genital tract. Recent research findings offer a promising perspective in the detection of endometrial cancer, but certain questions need to be addressed in order to accelerate the implementation of novel technologies in a routine screening or clinical setting. We discuss here new perspectives on detection of endometrial cancer using genomic and other biomarkers in minimally invasive sampling methods with a special focus on public health classic screening criteria, highlighting current gaps in knowledge.